Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$53M+13.8% YoY

Gross Profit

$38M72.2% margin

Operating Income

$4M8.3% margin

Net Income

$440,0000.8% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-7.4%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$434M

Total Liabilities

$235M

Stockholders' Equity

$200M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$46M	+13.8%
Gross Profit	$38M	$26M	+48.0%
Operating Income	$4M	$7M	-32.7%
Net Income	$440,000	$2M	-80.3%

Revenue Segments

Sales Of Generic Pharmaceutical Products

$32M56%

Sales Of Branded Pharmaceutical Products

$18M31%

Sales Of Contract Manufactured Products

$6M11%

Royalties From Licensing Agreements

$577,0001%

Other Revenues

$411,0001%

Product Development Services

$320,0001%

Geographic Segments

United States

$51M96%

Canada

$2M4%